VEC.L Share News (VEC)

DIRECTOR DEALINGS: Vectura Chairman Buys 80,000 Shares

Vectura Group gains from Skyepharma merger as it raises expectations

(ShareCast News) - Inhaled airways disease focused business Vectura Group raised expectations for 2016 as it said it is making progress with the June Skyepharma merger. The company raised revenue expectations for the nine month period ended 31 December, due to strong growth from its partnered market

LONDON MARKET OPEN: Mixed Open; Ashtead Leads Gainers, Worldpay Losers

Breezhaler better than Seretide, says Vectura

(ShareCast News) - Inhaled airways disease focused pharmaceuticals company Vectura Group confirmed an announcement from its alliance partner Novartis on Monday, that new analyses from the head-to-head FLAME study confirmed that Ultibro Breezhaler is a "more effective option" for patients at risk of

Vectura inhaler collaboration with Novartis improves treatment persistence

(ShareCast News) - Novartis has published data about a respiratory drug combination delivered using an inhaler designed in collaboration with Vectura that shows patients are twice as likely to persist with treatment over 12 months than with a popular product already on the market. Patients using Nov

LONDON MARKET OPEN: Bunzl Leads Gainers As Miners Drag On FTSE 100

Vectura Group Says Flutiform Has Failed To Meet Primary Endpoint

Investec resumes coverage on Vectura at 'buy'

(ShareCast News) - Investec resumed coverage on Vectura at 'buy' with a 200p price target following completion of the SkyePharma deal. "In our view, the benefits from a broader royalty base, improved cash flows, as well as an enhanced competency set, are yet to be fully reflected in the share price,

Vectura to receive milestone payment for EXPAREL

(ShareCast News) - Inhaled airways disease focused company Vectura Group announced on Friday that a sales milestone receipt of $8m has been triggered following confirmation by Pacira Pharmaceuticals that worldwide annual net sales of EXPAREL, on a cash received basis to 30 June, were above $250m. Th

Your inhaler's watching you: drugmakers race for smart devices

* Digitally connected devices aim to track medicine use * GSK, AstraZeneca, Novartis all working on smart inhalers * Innovation drive comes as sector faces growing competition By Ben Hirschler LONDON, July 20 (Reuters) - Makers of inhalers to treat asthma and chronic lung

BROKER RATINGS SUMMARY: Macquarie Raises Banks, HSBC Lowers Grocers

Vectura Group Says Lyon Manufacturing Facility Lease Returned

Vectura Says Partner Ablynx Exercises Commercial Licence Option

Director dealings: Skyepharma CFO gets cash injection from Vectura merger

(ShareCast News) - Skyepharma's chief financial officer Andrew Derodra has pocketed a healthy cash injection after the completion of the merger with Vectura. Derodra exercised nil-cost options over 150,000 Skyepharma shares that were a bonus in his long-term incentive plan that vested on completion

LONDON MARKET CLOSE: Global Economy, EU Vote Worries Hit Sentiment